AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32758384 — intervention group
Group type: COMPARATOR
Intervention: late parenteral nutrition (late-PN)
Number of subjects: 786
Study 32400499 — intervention group
Group type: EXPERIMENTAL
Intervention: subharmonic complemented discrete Fourier transformation (DFT) method
Number of subjects: 0
Study 32400499 — intervention group
Group type: EXPERIMENTAL
Intervention: sparse spectrum (SS) technique
Number of subjects: 0
Study 32400499 — intervention group
Group type: EXPERIMENTAL
Intervention: sparse spectrum technique with uniform wave vectors (SU)
Number of subjects: 0
Study 32400499 — intervention group
Group type: EXPERIMENTAL
Intervention: randomized DFT technique
Number of subjects: 0
Study 32400499 — intervention group
Group type: EXPERIMENTAL
Intervention: optimization-based (OB) method
Number of subjects: 0
Study 32400499 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 36197173 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind mapping combined with PBL teaching
Number of subjects: 89
Study 36197173 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture-based learning
Number of subjects: 89
Study 32634624 — intervention group
Group type: EXPERIMENTAL
Intervention: Biennial fecal occult blood test (FOBT) screening
Number of subjects: 108484
Study 32634624 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 108484
Study 33100184 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity‐only intervention (PA‐only)
Number of subjects: 0
Study 33100184 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity plus fatigue self-management intervention (FM+)
Number of subjects: 0
Study 33100184 — intervention group
Group type: COMPARATOR
Intervention: Contact-control intervention (CC)
Number of subjects: 0
Study 34130556 — intervention group
Group type: EXPERIMENTAL
Intervention: Written benefit finding (three consecutive days of writing about positive thoughts and feelings)
Number of subjects: 91
Study 34130556 — intervention group
Group type: COMPARATOR
Intervention: Control (unemotively describe the events of the previous day)
Number of subjects: 91
Study 33444161 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Glargine 300 units · mL-1 (Gla-300)
Number of subjects: 22
Study 33444161 — intervention group
Group type: COMPARATOR
Intervention: Insulin Degludec 100 units · mL-1 (Deg-100)
Number of subjects: 22
Study 35643381 — intervention group
Group type: EXPERIMENTAL
Intervention: Shen-Yuan-Dan (SYD) capsules (4 capsules, 3 times a day, with a further 4 capsules 2 hours before PCI)
Number of subjects: 181
Study 35643381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study 35643381 — intervention group
Group type: EXPERIMENTAL
Intervention: Shen-Yuan-Dan (SYD) capsules
Number of subjects: 181
Study 34396512 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery closure at the origin from the internal iliac artery (n=90)
Number of subjects: 180
Study 34396512 — intervention group
Group type: COMPARATOR
Intervention: Uterine artery closure at the uterus level (n=90)
Number of subjects: 180
Study 32542356 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk Training
Number of subjects: 39
Study 32542356 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Training
Number of subjects: 39
Study 34636853 — intervention group
Group type: EXPERIMENTAL
Intervention: UV-C light plus standard environmental cleaning
Number of subjects: 302
Study 34636853 — intervention group
Group type: COMPARATOR
Intervention: Standard environmental cleaning (Control)
Number of subjects: 302
Study 32422234 — intervention group
Group type: EXPERIMENTAL
Intervention: TMPRSS6 rs855791 polymorphism in iron-deficient students
Number of subjects: 108
Study 32422234 — intervention group
Group type: EXPERIMENTAL
Intervention: TMPRSS6 rs2111833 polymorphism in iron-deficient students
Number of subjects: 108
Study 32422234 — intervention group
Group type: COMPARATOR
Intervention: TMPRSS6 rs855791 polymorphism in healthy students
Number of subjects: 108
Study 32422234 — intervention group
Group type: COMPARATOR
Intervention: TMPRSS6 rs2111833 polymorphism in healthy students
Number of subjects: 108
Study 35001671 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RG)
Number of subjects: 38
Study 35001671 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training with Core Training (RCG)
Number of subjects: 38
Study 35001671 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 38
Study 32932860 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional neuronal networks for classification of gastritis subtypes
Number of subjects: 135
Study 32932860 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional neuronal networks for classification of type B gastritis
Number of subjects: 135
Study 35534778 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient powder (MNP)
Number of subjects: 1704
Study 35534778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1704
Study 34941543 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical blog
Number of subjects: 266
Study 34941543 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal narrative blog
Number of subjects: 266
Study 34941543 — intervention group
Group type: EXPERIMENTAL
Intervention: General medical blogs
Number of subjects: 266
Study 34941543 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to accessing care
Number of subjects: 266
Study 32935565 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS-guided PCNL
Number of subjects: 56
Study 32935565 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound-guided PCNL
Number of subjects: 56
Study 32794482 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy (triple therapy + colloidal bismuth subcitrate)
Number of subjects: 196
Study 32794482 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (amoxicillin, clarithromycin, and omeprazole)
Number of subjects: 196
Study 35322563 — intervention group
Group type: EXPERIMENTAL
Intervention: Simethicone
Number of subjects: 30
Study 35322563 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 30
Study 35285657 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward-viewing endoscope
Number of subjects: 692
Study 35285657 — intervention group
Group type: COMPARATOR
Intervention: Proximal retroflexion
Number of subjects: 692
Study 35285657 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 692
Study 33956476 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 400
Study 33956476 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 400
Study 33956476 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 400
Study 35637453 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife local implementation leaders
Number of subjects: 27
Study 35637453 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor local implementation leaders
Number of subjects: 27
Study 32307124 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling intervention implemented at the hospital level for firearm storage
Number of subjects: 575
Study 32307124 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling intervention implemented at the hospital level for medication storage
Number of subjects: 575
Study 32307124 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling intervention for medication storage after adjusting for time
Number of subjects: 575
Study 32307124 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling intervention for firearm storage after adjusting for time
Number of subjects: 575
Study 36124653 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen inhalation and hydrogen dissolved in water
Number of subjects: 20
Study 36124653 — intervention group
Group type: COMPARATOR
Intervention: Placebo air inhalation
Number of subjects: 20
Study 32109880 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent carbohydrate ingestion (15 × 5 g every 5 min)
Number of subjects: 6
Study 32109880 — intervention group
Group type: COMPARATOR
Intervention: Late bolus carbohydrate ingestion (1 × 75 g after 75 min)
Number of subjects: 6
Study 34355628 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intervention group (IG) - 34 sessions of group singing over 4 months
Number of subjects: 149
Study 34355628 — intervention group
Group type: COMPARATOR
Intervention: Wait-list active control group (WLG)
Number of subjects: 149
Study 34313217 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysergic acid diethylamide (LSD)
Number of subjects: 0
Study 34313217 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-subject model fitting
Number of subjects: 0
Study 35304280 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled ciclesonide
Number of subjects: 217
Study 35304280 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 217
Study 35304280 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide
Number of subjects: 217
Study 32752026 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application providing breastfeeding information
Number of subjects: 1000
Study 32752026 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving non-breastfeeding information via smartphone app
Number of subjects: 1000
Study 35931598 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone iodine (PI) disinfecting solution
Number of subjects: 80
Study 37458100 — intervention group
Group type: EXPERIMENTAL
Intervention: PADN plus PDE‐5i
Number of subjects: 128
Study 37458100 — intervention group
Group type: COMPARATOR
Intervention: Sham plus PDE‐5i
Number of subjects: 128
Study 34625041 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole lauroxil (AL) 1064 mg q8wk
Number of subjects: 200
Study 34625041 — intervention group
Group type: COMPARATOR
Intervention: Paliperidone palmitate (PP) 156 mg q4wk
Number of subjects: 200
Study 32988521 — intervention group
Group type: COMPARATOR
Intervention: NC diet (0.22% for 1‐14 D/0.18% for 15‐35 D)
Number of subjects: 560
Study 32988521 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase supplementation at 5,000 to 10,000 FTU/kg to NC diets
Number of subjects: 560
Study 32988521 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase supplementation
Number of subjects: 560
Study 34030187 — intervention group
Group type: EXPERIMENTAL
Intervention: Collimation
Number of subjects: 39
Study 34030187 — intervention group
Group type: COMPARATOR
Intervention: Standard fluoroscopy
Number of subjects: 39
Study 37463582 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 55
Study 37463582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 33493608 — intervention group
Group type: EXPERIMENTAL
Intervention: Cookies that were both physically and psychologically anthropomorphized
Number of subjects: 188
Study 33493608 — intervention group
Group type: COMPARATOR
Intervention: Cookies that were physically anthropomorphized only
Number of subjects: 188
Study 33493608 — intervention group
Group type: COMPARATOR
Intervention: Cookies that were not anthropomorphized
Number of subjects: 188
Study 34117400 — intervention group
Group type: EXPERIMENTAL
Intervention: Single site phacotrabeculectomy with MMC 0.2 mg/mL
Number of subjects: 108
Study 34117400 — intervention group
Group type: COMPARATOR
Intervention: Twin-site phacotrabeculectomy with MMC 0.2 mg/mL
Number of subjects: 108
Study 34076495 — intervention group
Group type: EXPERIMENTAL
Intervention: Pluchea indica tea (PIT) 1.5g once daily for 12 weeks
Number of subjects: 45
Study 34076495 — intervention group
Group type: COMPARATOR
Intervention: Placebo tea
Number of subjects: 45
Study 34076495 — intervention group
Group type: EXPERIMENTAL
Intervention: Camellia sinensis tea (CST) 1.5g once daily for 12 weeks
Number of subjects: 45
Study 33377218 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nebulised unfractionated heparin (UFH)
Number of subjects: 0
Study 33377218 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 33351359 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote consultation (RC) group
Number of subjects: 180
Study 33351359 — intervention group
Group type: COMPARATOR
Intervention: Traditional control (TC) group
Number of subjects: 180
Study 33622510 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach goal-enhanced intervention
Number of subjects: 224
Study 33622510 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance goal-enhanced intervention
Number of subjects: 224
Study 33622510 — intervention group
Group type: EXPERIMENTAL
Intervention: No-goal intervention
Number of subjects: 224
Study 33622510 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 224
Study 33744986 — intervention group
Group type: EXPERIMENTAL
Intervention: ModraDoc006/r 30–20/100–100
Number of subjects: 28
Study 33744986 — intervention group
Group type: EXPERIMENTAL
Intervention: ModraDoc006/r 30–20/200–100
Number of subjects: 28
Study 33080746 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES
Number of subjects: 37
Study 33080746 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation program only (non‐NMES group)
Number of subjects: 37
Study 34412103 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept monotherapy
Number of subjects: 48
Study 33123739 — intervention group
Group type: EXPERIMENTAL
Intervention: PPT+20%
Number of subjects: 22
Study 33123739 — intervention group
Group type: EXPERIMENTAL
Intervention: PPT+30%
Number of subjects: 22
Study 33123739 — intervention group
Group type: EXPERIMENTAL
Intervention: PPT+40%
Number of subjects: 22
Study 33123739 — intervention group
Group type: EXPERIMENTAL
Intervention: PPT+50%
Number of subjects: 22
Study 33123739 — intervention group
Group type: EXPERIMENTAL
Intervention: PPT+20%, PPT+30%, PPT+40%, PPT+50%
Number of subjects: 22
Study 33369500 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical matching technique
Number of subjects: 0
Study 34773438 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (microscope-based training)
Number of subjects: 60
Study 34773438 — intervention group
Group type: COMPARATOR
Intervention: Group A (no additional training)
Number of subjects: 60
Study 34781822 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative video about cervical cancer
Number of subjects: 63
Study 34781822 — intervention group
Group type: COMPARATOR
Intervention: Video on healthy habits (active control)
Number of subjects: 63
Study 34781822 — intervention group
Group type: COMPARATOR
Intervention: No intervention (passive control)
Number of subjects: 63
Study 34781822 — intervention group
Group type: COMPARATOR
Intervention: All groups (including controls)
Number of subjects: 63
Study 34135953 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel firefly algorithm with deep learning for test data generation
Number of subjects: 0
Study 34135953 — intervention group
Group type: COMPARATOR
Intervention: Traditional firefly algorithm
Number of subjects: 0
Study 32270637 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with opioid drugs (Oxycodone hydrochloride prolonged-release tablet)
Number of subjects: 60
Study 32270637 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone hydrochloride prolonged-release tablet (Control group)
Number of subjects: 60
Study 34862101 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-initiated follow-up (PIFU)
Number of subjects: 34
Study 34862101 — intervention group
Group type: COMPARATOR
Intervention: Routine scheduled follow-up
Number of subjects: 34
Study 33933181 — intervention group
Group type: EXPERIMENTAL
Intervention: MMM intervention
Number of subjects: 241
Study 33933181 — intervention group
Group type: COMPARATOR
Intervention: HE control
Number of subjects: 241
Study 35195725 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (100 mg)
Number of subjects: 87
Study 35195725 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg)
Number of subjects: 87
Study 35195725 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 87
Study 35195725 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall ERAS
Number of subjects: 87
Study 33547453 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to online misinformation about COVID-19 vaccines
Number of subjects: 0
Study 33547453 — intervention group
Group type: COMPARATOR
Intervention: Factual information about COVID-19 vaccines
Number of subjects: 0
Study 35638086 — intervention group
Group type: EXPERIMENTAL
Intervention: ilixadencel/sunitinib (ILIXA/SUN)
Number of subjects: 88
Study 35638086 — intervention group
Group type: COMPARATOR
Intervention: sunitinib alone (SUN)
Number of subjects: 88
Study 32520594 — intervention group
Group type: COMPARATOR
Intervention: Novolog
Number of subjects: 19
Study 32520594 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiasp
Number of subjects: 19
Study 34812114 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-h urethral catheter removal
Number of subjects: 300
Study 34812114 — intervention group
Group type: COMPARATOR
Intervention: 24-h urethral catheter removal
Number of subjects: 300
Study 35351381 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.5 mg/kg)
Number of subjects: 300
Study 35351381 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet computer
Number of subjects: 300
Study 35351381 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 300
Study 33605075 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-etched enamel (EA)
Number of subjects: 40
Study 33605075 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-etched dentin (DA)
Number of subjects: 40
Study 33605075 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-conditioned enamel (EL)
Number of subjects: 40
Study 33605075 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-conditioned dentin (DL)
Number of subjects: 40
Study 32652432 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance enterography and colonography (MREC) with water enema and intravenous spasmolytics
Number of subjects: 217
Study 32652432 — intervention group
Group type: EXPERIMENTAL
Intervention: Water enema and spasmolytics
Number of subjects: 217
Study 32652432 — intervention group
Group type: EXPERIMENTAL
Intervention: Spasmolytics
Number of subjects: 217
Study 32652432 — intervention group
Group type: COMPARATOR
Intervention: Gastric content, age, gender, and body mass
Number of subjects: 217
Study 34991040 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-video group (n=23)
Number of subjects: 60
Study 34991040 — intervention group
Group type: COMPARATOR
Intervention: No video control group
Number of subjects: 60
Study 33222190 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV RNA response (either >2 log HBV RNA decline or >1 log decline resulting in an undetectable value at on-treatment week 24)
Number of subjects: 279
Study 33222190 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV RNA response
Number of subjects: 279
Study 33222190 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV RNA response with >1 log HBsAg decline
Number of subjects: 279
Study 33002009 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 65487
Study 33002009 — intervention group
Group type: COMPARATOR
Intervention: Non-acupuncture (control)
Number of subjects: 65487
Study 36397216 — intervention group
Group type: EXPERIMENTAL
Intervention: Huayu Tongluo moxibustion combined with intradermal needling (6 times a week for 4 weeks)
Number of subjects: 50
Study 36397216 — intervention group
Group type: COMPARATOR
Intervention: Western medication (paroxetine hydrochloride tablets, 20 mg once daily for 4 weeks, max 40 mg/d)
Number of subjects: 50
Study 36067489 — intervention group
Group type: EXPERIMENTAL
Intervention: Macleaya cordata extract (MCE) at 100 mg/kg
Number of subjects: 6
Study 36067489 — intervention group
Group type: COMPARATOR
Intervention: Control group (commercial diet)
Number of subjects: 6
Study 33864634 — intervention group
Group type: COMPARATOR
Intervention: Octanoic acid (OA) treatment over a 2-week period
Number of subjects: 16
Study 33864634 — intervention group
Group type: COMPARATOR
Intervention: Voice Handicap Index-10 assessment
Number of subjects: 16
Study 33864634 — intervention group
Group type: COMPARATOR
Intervention: Intrasubject consistency measures
Number of subjects: 16
Study 32412991 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body resilience intervention (Stress Management and Resiliency Training: A Relaxation Response Resiliency Program), 8-week duration.
Number of subjects: 99
Study 33761856 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular stimulation every 2 weeks for 6 months
Number of subjects: 15
Study 33761856 — intervention group
Group type: COMPARATOR
Intervention: Nonstimulation (control group)
Number of subjects: 15
Study 32151101 — intervention group
Group type: EXPERIMENTAL
Intervention: Bite splint + Platelet-rich plasma injection
Number of subjects: 80
Study 32151101 — intervention group
Group type: EXPERIMENTAL
Intervention: Bite splint + Sodium hyaluronate injection
Number of subjects: 80
Study 32151101 — intervention group
Group type: EXPERIMENTAL
Intervention: Bite splint + Betamethasone injection
Number of subjects: 80
Study 32151101 — intervention group
Group type: COMPARATOR
Intervention: Bite splint only
Number of subjects: 80
Study 35835337 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (0.4 mg/ml for 2 minutes)
Number of subjects: 242
Study 32807709 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive 2-week CRP with booster sessions
Number of subjects: 497
Study 32807709 — intervention group
Group type: COMPARATOR
Intervention: Standard 8-week CRP
Number of subjects: 497
Study 32590828 — intervention group
Group type: EXPERIMENTAL
Intervention: Female authorship
Number of subjects: 2146
Study 32590828 — intervention group
Group type: EXPERIMENTAL
Intervention: Female authorship over time
Number of subjects: 2146
Study 32590828 — intervention group
Group type: COMPARATOR
Intervention: Characteristics of trials by author gender
Number of subjects: 2146
Study 35807872 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa flavanols (CF) 790 mg
Number of subjects: 11
Study 35807872 — intervention group
Group type: COMPARATOR
Intervention: Control (non-diabetic group)
Number of subjects: 11
Study 33527729 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate tissue level (ITL) abutment
Number of subjects: 64
Study 33527729 — intervention group
Group type: COMPARATOR
Intervention: Regular healing abutment (Control)
Number of subjects: 64